You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/64649
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLastoria, Joel Carlos-
dc.contributor.authorMarques, Silvio Alencar-
dc.contributor.authorDillon, N. L.-
dc.contributor.authorLastoria, S.-
dc.contributor.authorCuri, P. R.-
dc.date.accessioned2014-05-27T11:18:01Z-
dc.date.accessioned2016-10-25T18:13:36Z-
dc.date.available2014-05-27T11:18:01Z-
dc.date.available2016-10-25T18:13:36Z-
dc.date.issued1995-12-01-
dc.identifierhttp://cat.inist.fr/?aModele=afficheN&cpsidt=2955274-
dc.identifier.citationMedicina Cutanea Ibero-Latino-Americana, v. 23, n. 8, p. 377-382, 1995.-
dc.identifier.issn0210-5187-
dc.identifier.urihttp://hdl.handle.net/11449/64649-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/64649-
dc.description.abstractThe authors studied the incidence of thrombophlebitis in 41 patients treated intravenously with amphotericin B. The patients were divided in two different group: Group 1: patients treated with amphotericin B and hydrocortisone with heparin (1000 UI); Group 2: patients treated with amphotericin B and hydrocortisone. The results showed 23.81% of incidence of thrombophlebitis in Group 1 and 90% in Group 2. Thrombophlebitis in Group 1 ranged from mild to moderate without any change during the drug therapy. In Group 2, the incidence was 66.67% and the thrombophlebitis were severe being necessary the withdrawn of the drugs in 35.0% of the cases. We concluded that heparin, in low doses, in association with amphotericin B, was an efficient drug preventing or reducing the development of thrombophlebitis.en
dc.format.extent377-382-
dc.language.isopor-
dc.sourceScopus-
dc.subjectamphotericin B-
dc.subjectheparin-
dc.subjectthrombophlebitis-
dc.subjectamphotericin b-
dc.subjecthydrocortisone-
dc.subjectadolescent-
dc.subjectadult-
dc.subjectaged-
dc.subjectclinical article-
dc.subjectclinical trial-
dc.subjectcontrolled clinical trial-
dc.subjectcontrolled study-
dc.subjectdrug effect-
dc.subjectfemale-
dc.subjecthuman-
dc.subjectincidence-
dc.subjectmale-
dc.titlePREVENCAO DE TROMBOFLEBITES PELO USO DE HEPARINA EM PACIENTES TRATADOS COM ANFOTERICINA Bpt
dc.title.alternativePrevention of thrombophlebitis with the use of heparin in patients treated with amphotericin Ben
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationFaculdade de Medicina Departamento de Dermatologia, Rubiao Jr., CEP 18618-000 Botucatu, SP-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofMedicina Cutanea Ibero-Latino-Americana-
dc.identifier.scopus2-s2.0-0029616720-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.